Cazzaniga, M. E. http://orcid.org/0000-0003-1756-6935
Vallini, I.
Montagna, E.
Amoroso, D.
Berardi, R.
Butera, A.
Cagossi, K.
Cavanna, L.
Ciccarese, M.
Cinieri, S.
Cretella, E.
De Conciliis, E.
Febbraro, A.
Ferraù, F.
Ferzi, A.
Baldelli, A.
Fontana, A.
Gambaro, A. R.
Garrone, O.
Gebbia, V.
Generali, D.
Gianni, L.
Giovanardi, F.
Grassadonia, A.
Leonardi, V.
Marchetti, P.
Sarti, S.
Musolino, A.
Nicolini, M.
Putzu, C.
Riccardi, F.
Santini, D.
Saracchini, S.
Sarobba, M. G.
Schintu, M. G.
Scognamiglio, G.
Spadaro, P.
Taverniti, C.
Toniolo, D.
Tralongo, P.
Turletti, A.
Valenza, R.
Valerio, M. R.
Vici, P.
Di Mauro, P.
Cogliati, V.
Capici, S.
Clivio, L.
Torri, V.
Cazzaniga, M. E.
Vallini, I.
Montagna, E.
Amoroso, D.
Berardi, R.
Butera, A.
Cagossi, K.
Cavanna, L.
Ciccarese, M.
Cinieri, S.
Cretella, E.
De Conciliis, E.
Febbraro, A.
Ferraù, F.
Ferzi, A.
Baldelli, A.
Fontana, A.
Gambaro, A. R.
Garrone, O.
Gebbia, V.
Generali, D.
Gianni, L.
Giovanardi, F.
Grassadonia, A.
Leonardi, V.
Marchetti, P.
Sarti, S.
Musolino, A.
Nicolini, M.
Putzu, C.
Riccardi, F.
Santini, D.
Saracchini, S.
Sarobba, M. G.
Schintu, M. G.
Scognamiglio, G.
Spadaro, P.
Taverniti, C.
Toniolo, D.
Tralongo, P.
Turletti, A.
Valenza, R.
Valerio, M. R.
Vici, P.
Clivio, L.
Torri, V.
,
Funding for this research was provided by:
Università degli Studi di Milano - Bicocca
Article History
Received: 13 August 2021
Accepted: 26 August 2021
First Online: 21 September 2021
Declarations
:
: Author Prof. Cazzaniga has a role as consultant/advisory role for: Pierre-Fabre, Roche; Novartis; Lilly; Celgene. Author Vallini I. declares that she has no conflict of interest; Author Dr Montagna has a role as consultant/advisory role for: Pierre-Fabre; Author Dr Amoroso declares that he has no conflict of interest; Author Dr Berardi declares that she has no conflict of interest; Author Dr Butera declares that she has no conflict of interest; Author Dr Cagossi declares that she has no conflict of interest; Author Dr Cavanna has a role as consultant/advisory role for: Astra Zeneca, Ipsen, Janssen; Author Dr Ciccarese declares that she has no conflict of interest;, Author Dr Cinieri has a role as consultant/advisory role for: Ely Lilly, Author Dr Cretella declares that she has no conflict of interest, Author Dr De Conciliis declares that he has no conflict of interest, Author Dr Febbraro declares that he has no conflict of interest, Author Dr Ferraù declares that he has no conflict of interest, Author Dr Ferzi declares that she has no conflict of interest, Author Dr Baldelli declares that he has no conflict of interest, Author Dr Fontana has a role as consultant/advisory role for: Novartis, Roche, Daiichi Sankyo, Pierre Phabre, Eli Lilly; Author Dr Gambaro declares that she has no conflict of interest, Author Dr Garrone declares that she has no conflict of interest, Author Dr Gebbia declares that he has no conflict of interest, Author Dr Generali has received a remuneration of 5.000 € and had a role as consultant/advisory role for: Novartis, FMI, Istituto Gentili, Roche, Pfizer, Ely Lilly, Author Dr Gianni declares that he has no conflict of interest, Author Dr Giovanardi declares that he has no conflict of interest,, Author Dr Grassadonia declares that he has no conflict of interest, Author Dr Leonardi declares that she has no conflict of interest, Author Dr Marchetti declares that he has no conflict of interest, Author Dr Sarti declares that she has no conflict of interest, Author Dr Musolino remuneration acting as consultant/advisory role for: Eisai, Ely Lilly, Seagen, Novartis, Roche; Author Dr Nicolini declares that he has no conflict of interest, Author Dr Putzu declares that he has no conflict of interest,, Author Dr Riccardi declares that he has no conflict of interest,, Author Dr Santini has a role as consultant/advisory role for: Novartis, Lilly, Eisai; Author Dr Saracchini declares that she has no conflict of interest,, Author Dr Sarobba declares that she has no conflict of interest,, Author Dr Schintu declares that she has no conflict of interest, Author Dr Scognamiglio declares that he has no conflict of interest, Author Dr Spadaro declares that he has no conflict of interest,. Author Dr Taverniti declares that he has no conflict of interest, Author Dr Toniolo declares that he has no conflict of interest,, Author Dr Tralongo declares that he has no conflict of interest, Author Dr Turletti declares that she has no conflict of interest, Author Dr Valenza declares that he has no conflict of interest,, Author Dr Valerio declares that he has no conflict of interest, Author Dr Vici Santini has a role as consultant/advisory role for: Roche, Pfizer, Novartis, Gentili, Eli Lilly; Author Clivio declares that he has no conflict of interest and Author Torri declares that he has no conflict of interest.
: All procedures performed in our study are in accordance with the ethical standards of our institutional review board.
: The study was conducted in accordance with the 1987 Declaration of Helsinki and adhered to Good Clinical Practice guidelines. Approval of the protocol was obtained from the local ethics committee for each participating centre; all patients were required to give written informed consent before enrolment and to comply with the protocol for the duration of the study.